Glycosylation-mediated inhibition of factor x

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 9/48 (2006.01) A61K 38/43 (2006.01) A61K 38/47 (2006.01) A61K 38/48 (2006.01) A61K 38/55 (2006.01) A61K 39/395 (2006.01) C07K 14/42 (2006.01) C07K 14/745 (2006.01) C07K 16/36 (2006.01) C12N 9/64 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2132518

2132518 9318782 PCTABS00025 Reagents that specifically bind a carbohydrate target wherein sialic acid is linked at the nonreducing terminus of a glycoside to a galactose or galactosamine residue through an .alpha.2-6 linkage are able to inhibit the conversion of human Factor X to human Factor Xa. These reagents (SA/Gal/GalNAc binding reagents) as well as other strategies for inhibiting the conversion of Factor X to Factor Xa are useful in treating thrombosis, inflammation and other conditions associated with excess thrombin activity.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Glycosylation-mediated inhibition of factor x does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Glycosylation-mediated inhibition of factor x, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glycosylation-mediated inhibition of factor x will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1932304

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.